SLXP

Salix Pharmaceuticals, Ltd. Press Releases

$114.92
*  
1.18
1.02%
Get SLXP Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading SLXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Salix Pharmaceuticals, Ltd. Of Upcoming Deadline
12/24/2014 5:04:00 PM - Business Wire


Stocks in the News: Analyst Coverage on Encana, Unisys, Salix, Cerus and Eli Lilly
12/17/2014 9:20:00 AM - PR Newswire


Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP
12/17/2014 8:30:00 AM - Business Wire
▲3.71 % Price Change since this news event. The Volume Ratio is 1.4.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix Pharmaceuticals Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for IBS-D Approval Timeline, and Provides Preliminary Guidance for 2015 and 2016
12/16/2014 7:00:00 AM - Business Wire


Salix Pharmaceuticals Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for IBS-D Approval Timeline, and Provides Preliminary Guidance for 2015 and 2016
12/16/2014 7:00:00 AM - Business Wire
▲11.54 % Price Change since this news event. The Volume Ratio is 5.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Salix Pharmaceuticals Ltd and Certain Officers - SLXP
12/12/2014 7:40:00 PM - Market Wire
▲14.92 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action Litigation - SLXP
12/10/2014 7:48:00 PM - Business Wire
▲9.45 % Price Change since this news event. The Volume Ratio is 0.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix Pharmaceuticals Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
11/25/2014 10:57:00 AM - Business Wire


Salix Pharmaceuticals Announces Plan to Augment Board of Directors
11/24/2014 4:01:00 PM - Business Wire


Lieff Cabraser Announces Class Action Litigation Against Salix Pharmaceuticals, Inc. - SLXP
11/13/2014 3:05:00 PM - Business Wire
▲18.05 % Price Change since this news event. The Volume Ratio is 0.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Salix Pharmaceuticals Inc. (SLXP) To Contact The Firm
11/11/2014 5:23:00 PM - PR Newswire
▲16.26 % Price Change since this news event. The Volume Ratio is 0.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lifshitz & Miller Law Firm Announces Investigation of Barrett Business Services, Inc., Bio-Rad Laboratories, Inc., Pingtan Marine Enterprise Ltd., Rayonier Inc. and Salix Pharmaceuticals, Ltd.
11/11/2014 12:10:00 PM - PR Newswire


Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Salix Pharmaceuticals, Ltd.
11/10/2014 4:28:00 PM - Business Wire
▲22.42 % Price Change since this news event. The Volume Ratio is 0.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Wolf Popper LLP Announces Investigation on Behalf of Investors in Salix Pharmaceuticals Ltd.
11/10/2014 12:09:00 PM - PR Newswire
▲22.54 % Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Deadline in Lawsuit for Investors in Salix Pharmaceuticals, Ltd. (SLXP) Shares Announced by Shareholders Foundation
11/10/2014 9:30:00 AM - GlobeNewswire


SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
11/7/2014 10:00:00 PM - Business Wire
▲25.86 % Price Change since this news event. The Volume Ratio is 0.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
11/7/2014 8:10:00 PM - PR Newswire
▲25.86 % Price Change since this news event. The Volume Ratio is 0.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
11/7/2014 5:23:00 PM - Business Wire
▲25.31 % Price Change since this news event. The Volume Ratio is 0.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


U.S. Securities and Exchange Commission Approves NASDAQ Stock Market LLC Rule Governing the Listing and Trading of Exchange-Traded Managed Funds
11/7/2014 5:22:00 PM - PR Newswire


Salix Pharmaceuticals Ltd. Investigated by Block & Leviton LLP After The Company Announces Resignation Of Its Chief Financial Officer And Reduced Financial Forecasts
11/7/2014 11:09:00 AM - PR Newswire
▲31.47 % Price Change since this news event. The Volume Ratio is 17.65.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


SALIX SHAREHOLDER ALERT: Investor Rights Firm Johnson & Weaver, LLP Announces Investigation of Salix Pharmaceuticals Ltd.
11/6/2014 7:20:00 PM - Business Wire
▲32.17 % Price Change since this news event. The Volume Ratio is 22.23.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix Pharmaceuticals Reports 3Q2014 Results
11/6/2014 4:05:00 PM - Business Wire
▼-17.06 % Price Change since this news event. The Volume Ratio is 26.69.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix Pharmaceuticals Appoints Acting Chief Financial Officer
11/6/2014 4:01:00 PM - Business Wire
▼-17.06 % Price Change since this news event. The Volume Ratio is 26.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
11/3/2014 1:00:00 AM - Business Wire
▼-20.11 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call and Webcast
10/23/2014 7:00:00 AM - Business Wire
▼-16.50 % Price Change since this news event. The Volume Ratio is 0.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day